To submit a proposal for these opportunities:
Interested candidates must send a one-page summary of their research proposal and their biosketch in pdf format via the Limited Submission Portal.
The purpose of this funding opportunity announcement (FOA) is to solicit applications for pilot projects to elucidate a role for understudied proteins associated with rare diseases. Awards will support generation of preliminary data and/or tools around eligible understudied protein(s) with the intent of elucidating the function of these proteins in the context of rare disease and obtaining sufficient preliminary data and/or research resources for subsequent grant applications and/or drug discovery projects. A list of eligible proteins is provided below and in the FOA and all are members of druggable protein families that have a known association with a rare disease.
The NIH supports research on a broad range of diseases that are defined as rare; that is diseases affecting fewer than 200,000 individuals in the United States (per the Rare Disease Act of 2002). Collectively, there are an estimated 7,000 rare diseases, which affect approximately 25-30 million people in the United States. Most are serious or life-threatening, with a disproportionate number of rare diseases affecting children. At this time, effective treatments are available for fewer than 5%. The IDG Program has linked over 6,000 proteins to rare diseases, with over 80% of these proteins considered extremely understudied.
For the purposes of this FOA, eligible proteins are those that have an association with rare disease through data mining of the encyclopedia of rare disease annotations for precision medicine (eRAM) and Orphanet, are considered understudied (those proteins that lack small molecule binders and/or have limited biological characterization) and are within a protein family that is traditionally considered druggable.
Applications for the 2022 Gates Grubstake Fund awards are now being accepted. The Gates Center for Regenerative Medicine and CU Innovations annually make multiple awards of up to $350,000 to investigators who are researching and developing regenerative medicine related technologies, including therapeutics, diagnostics, devices, manufacturing, and platforms.
Applications are due on Wednesday, August 31, 2022.
To apply, and for further information, contact the Gates Center’s Entrepreneur in Residence and CU Innovations Director of Licensing Heather Callahan.
Register for the next quarterly Community Engagement Forum hosted by CCTSI and ACCORDS — Understanding and Appreciating the Capacities of the Community: How Partnerships Ensure More Equitable Research Design, Conduct, and Dissemination
Date: Wednesday, July 27, 2022
Time: 12:00-1:00 PM MT Zoom
The Peter J. Culshaw Family Junior Investigator Award is intended to support a promising young investigator developing novel ideas in type 1 diabetes.
This program will provide $50,000 a year for two years (renewable for a third year if adequate progress is demonstrated) to support development of research ideas and preparation to compete for external funding.
Letter of Intent due: July 15, 2022
Application submission due: August 1, 2022
For application questions please contact Alejandro Cervantes-Koerselman.
We are pleased to announce the first “Metabolic Imaging Workshop” hosted by the Colorado Nutrition and Obesity Research Center (NORC) and the Colorado Clinical and Translational Science Institute (CCTSI).
This workshop will provide a broad overview on state-of-the-art metabolic imaging modalities and protocols including PET/CT, PET/MRI, MRI/MRS, QCT, DXA, and ultrasound.
July 11-12, 2022
Wednesday, July 13, 2022 from 4 – 6 pm
Customer discovery is challenging. This session will focus on creating good questions for use during a customer discovery session.
This session will review the I-Corps@NCATS training program, discuss Business Canvas and Innovation Within tools and will focus on developing your question database.
More more information contact Claire McDonald.
This bulletin is distributed on the 1st & 3rd Tuesday of the month for the CU Anschutz Research Community.